对Neostigmine Plus Atropine对Dural穿孔后头痛的预防性影响的评估
Zahra Ahmadzade1, Mohammad Golparvar1, Shahram Sepiani1
1Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Advanced biomedical research
|July 12, 2023
概括
静脉注射neostigmine加上atropine可能会降低在骨科手术中脊髓麻醉后发生的持续性穿刺后头痛 (PDPH) 的发生率. 这种治疗显示出在接受下肢手术的患者中预防PDPH的潜力.
科学领域:
- 麻醉学 麻醉学
- 神经外科 神经外科
- 药理学 药理学是指药理学的学科.
背景情况:
- 持续性刺伤后头痛 (PDPH) 是脊髓麻醉的常见并发症.
- 在手术环境中,有效的PDPH预防和治疗策略至关重要.
- 下肢整形手术通常使用脊髓麻醉,增加PDPH风险.
研究的目的:
- 评估静脉注射尼奥斯蒂格明加上阿特罗宾在预防PDPH方面的疗效.
- 评估这种联合治疗对PDPH发病率和严重性的影响.
- 分析骨科手术中脊柱麻醉后5天的随访期内PDPH结果.
主要方法:
- 进行了一项随机的,受控的,双盲的临床试验.
- 99名接受下肢整形手术的患者接受了neostigmine (40μg/kg) 加上阿特罗宾 (20μg/kg) 或安慰剂静脉注射15分钟后.
- 在5天内,对PDPH的发生率,严重程度和持续时间以及药物副作用进行了监测.
主要成果:
- 与安慰剂组 (31名患者) 相比,在neostigmine-atropine组 (20名患者) 中观察到PDPH的发生率明显较低 (P=0.035).
- 群体之间PDPH的平均持续时间是可比的 (1.15 ± 0.48天对1.32 ± 0.54天,P=0.254).
- 没有报告副作用的显著差异.
结论:
- 预防性静脉注射neostigmine加上atropine可能会减少脊髓麻醉后PDPH的发生率.
- 这种组合疗法在接受下肢骨科手术的患者中显示出对管理PDPH的希望.
- 进一步的研究可能会探索最佳剂量和患者选择这项干预措施.
相关概念视频
01:19Depolarizing Blockers: Pharmocokinetics
353
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
353
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
719
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
719
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
460
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
460
01:26Anticholinesterase Agents: Poisoning and Treatment
923
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
923